Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
THE ROLE OF CLINICAL LABORATORY AND PATHOLOGICAL
PHYSIOLOGY IN DETERMINING ANTI-NUCLEAR ANTIBODIES (ANK) TITER
Raxmonov Shoxzodbek Oybek ugli
Assistant of the Departament of Pathology and Forensic Medicine, Central Asian Medical
University
Abstract:
Determination of the titer of antibodies against nuclear antigens is important in
the diagnosis of autoimmune diseases. This test is used to diagnose various autoimmune
diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, and other
collagenoses, by detecting antibodies produced by the div's immune system against its own
tissues. The clinical laboratory plays a central role in conducting tests for autoimmune
diseases. Antidiv titers and their specific types are determined using methods such as
immunofluorescence (IF) and enzyme-linked immunosorbent assay (ELISA). The results of
this test allow doctors to assess the patient's prognosis, determine treatment strategies, and
monitor the course of the disease. Pathophysiology, on the other hand, helps to understand
the mechanisms of autoimmune diseases by studying the causes and development processes
of the disease. New diagnostic and therapeutic methods are developed by studying the stages
of autoimmune reactions, inflammatory processes in the div, and pathological changes
caused by the immune system.
Keywords:
Antinuclear antigen antibodies, Autoimmune diseases, Systemic lupus
erythematosus (SLE), Scleroderma, Sjogren's syndrome, Mixed connective tissue disease,
Dermatomyositis, Polymyositis.
РОЛЬ КЛИНИЧЕСКОЙ ЛАБОРАТОРНОЙ И ПАТОЛОГИЧЕСКОЙ
ФИЗИОЛОГИИ В ОПРЕДЕЛЕНИИ ТИРА АНТИТЕЛ ПРОТИВ ЯДЕРНЫХ
АНТИГЕНОВ (АНК)
Аннотация:
Определение титра антител к ядерным антигенам имеет важное значение
в диагностике аутоиммунных заболеваний. Этот тест используется для диагностики
различных аутоиммунных заболеваний, включая системную красную волчанку (СКВ),
ревматоидный артрит и другие коллагенозы, путем выявления антител,
вырабатываемых иммунной системой организма против собственных тканей.
Клиническая лаборатория играет центральную роль в проведении тестов на
аутоиммунные заболевания. Титры антител и их конкретные типы определяют с
помощью таких методов, как иммунофлуоресценция (ИФ) и иммуноферментный
анализ (ИФА). Результаты этого теста позволяют врачам оценить прогноз пациента,
определить
стратегию
лечения
и
контролировать
течение
заболевания.
Патофизиология же помогает понять механизмы аутоиммунных заболеваний, изучая
причины и процессы развития заболевания. На основе изучения стадий
аутоиммунных реакций, воспалительных процессов в организме и патологических
изменений, вызванных иммунной системой, разрабатываются новые методы
диагностики и терапии.
Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Ключевые слова:
Антинуклеарные антигенные антитела, Аутоиммунные
заболевания, Системная красная волчанка (СКВ), Склеродермия, Синдром Шегрена,
Смешанное заболевание соединительной ткани, Дерматомиозит, Полимиозит.
Introduction
Today, the widespread prevalence of autoimmune diseases remains one of the pressing
problems of medicine. While the normal functioning of the immune system is aimed at
protecting the div from various external and internal threats, in autoimmune diseases this
system begins to attack its own healthy cells. This leads to the development of various
systemic diseases. Early diagnosis of autoimmune diseases is of great importance in their
prevention, control of the course and development of effective treatment methods.
Determination of the titer of antibodies to nuclear antigens is one of the main laboratory
tests in the diagnosis of autoimmune diseases. This test allows you to assess how the
immune system responds to its own nuclear structures. The role of the test for autoimmune
diseases is invaluable, especially in the diagnosis of systemic lupus erythematosus (SLE),
scleroderma, Sjogren's syndrome and other collagen diseases. These laboratory tests are
important not only for determining the presence of the disease, but also for monitoring its
course and response to treatment. The clinical laboratory plays a central role in determining
the titer of ANK. Modern technologies, in particular, immunofluorescence (IF), enzyme-
linked immunosorbent assay (ELISA) and blotting methods, provide highly accurate results.
Reliable and accurate clinical laboratory analysis results allow doctors to correctly diagnose
patients and choose effective treatment methods for them. At the same time, pathological
physiology contributes to the improvement of diagnostic and treatment methods by in-depth
study of the causes and mechanisms of development of these diseases. Having a complete
picture of how autoimmune reactions are formed, what factors provoke the disease and how
they affect the div is important for developing disease prevention strategies. The relevance
of this study is that autoimmune diseases have a complex pathogenesis, and the accuracy of
diagnosis is of great importance for their effective treatment. Studying the role of the clinical
laboratory and pathological physiology in determining the titer of autoimmune diseases will
serve to further improve the processes of diagnosing and treating these diseases. Therefore,
an in-depth analysis of this topic is one of the important directions in the field of modern
medicine and diagnostics.
Literature review and method
Antibodies against nuclear antigens are autoantibodies produced by the immune system
against various components of the cell nucleus. They are the main biomarkers of
autoimmune diseases and are used to diagnose diseases such as systemic lupus
erythematosus (SLE), scleroderma, and Sjogren's syndrome. Autoimmune diseases occur
when the immune system perceives proteins, DNA, RNA, or other antigens in the cell
nucleus as "foreign." This inappropriate immune response causes the div to attack its own
healthy cells. Genetic predisposition, environmental factors, viral infections, and hormonal
changes are considered factors that influence the development of autoimmune diseases.
Autoimmune diseases are divided into several types depending on the type of antigen they
bind to. Anti-dsDNA is produced against double-stranded DNA and is mainly associated
with systemic lupus erythematosus (SLE). Anti-Smith (Sm) antibodies are specific for SLE
and are rarely found in other diseases. Anti-RNP antibodies are associated with mixed
Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
connective tissue diseases. Anti-SSA/Ro and Anti-SSB/La antibodies are found in Sjogren's
syndrome and some other autoimmune diseases. Anti-centromere antibodies are associated
with scleroderma and CREST syndrome, and anti-topoisomerase I (Scl-70) is associated
with diffuse scleroderma. Autoimmune diseases are diagnosed in the laboratory using
various methods. Immunofluorescence (IF) microscopy is the main method for diagnosing
autoimmune diseases, which detects autoantibodies by visualizing the binding of
autoantibodies to nuclear components. Enzyme-linked immunosorbent assay (ELISA) is a
specific and sensitive method that allows you to distinguish between different types of
autoimmune diseases. Western blot is used to distinguish specific antibodies produced
against antigens. An increase in the titer of autoimmune diseases indicates the presence of
autoimmune diseases, but autoimmune diseases can also be detected at low levels in healthy
people. Therefore, the results of autoimmune diseases should be evaluated in conjunction
with clinical signs and other laboratory tests. Autoimmune diseases play an important role in
the diagnosis and monitoring of autoimmune diseases, and antidiv titers vary depending on
the course of the disease.
Antinuclear antigen antidiv testing is one of the important laboratory tests for diagnosing
and monitoring autoimmune diseases. This test helps to assess the div's immune response
to its own cells by detecting autoantibodies produced by the immune system. Autoimmune
disease testing is performed using several laboratory methods. Immunofluorescence (IF) is
widely used to detect the presence of autoimmune diseases. In this method, blood serum
taken from the patient is added to special nuclear substrates and the result is evaluated under
a microscope.
Autoimmune diseases play an important role in the diagnosis and monitoring of autoimmune
diseases, and antidiv titers vary depending on the course of the disease. Antinuclear
antigen antidiv testing is one of the important laboratory tests for diagnosing and
monitoring autoimmune diseases. This test helps to assess the immune response of the div
against its own cells by detecting autoantibodies produced by the immune system.
Autoimmune disease testing is performed using several laboratory methods.
Immunofluorescence (IF) is widely used to detect the presence of autoimmune diseases. In
this method, blood serum from the patient is added to special nuclear substrates and the
result is evaluated under a microscope. Autoimmune diseases are classified based on
different patterns and can be associated with different diseases. Enzyme-linked
immunosorbent assay (ELISA) allows for the accurate measurement of the amount of
autoimmune diseases. This method is highly sensitive and is used to detect a specific type of
autoantidiv. Autoimmune disease testing is important in the diagnosis and differential
diagnosis of autoimmune diseases. The results of the analysis are used to determine the
presence of autoimmune diseases, differentiate them from other diseases, assess the level of
disease activity, and monitor the effectiveness of treatment. For example, anti-dsDNA
antibodies are characteristic of systemic lupus erythematosus (SLE), and their titer increases
with increased disease activity. Anti-centromere antibodies are associated with scleroderma
and help determine the form of the disease. The results of the analysis for autoimmune
diseases can be positive or negative. A positive result indicates the possibility of an
autoimmune disease, but it must be evaluated in conjunction with clinical symptoms and
other laboratory tests to make a final diagnosis. In some cases, low levels of autoimmune
diseases can be detected even in healthy people, so it is important to interpret the results
correctly. The analysis for autoimmune diseases is also used to monitor and assess the
Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
prognosis of the disease. A decrease in the titer of autoimmune diseases during treatment
may indicate that the disease has entered a remission stage. An increase in the titer of
autoimmune diseases may also be associated with increased disease activity. Therefore, the
analysis of autoimmune diseases provides doctors with important information in monitoring
the course of the disease and determining the treatment strategy.
The role of pathological physiology
Pathological physiology studies the development of autoimmune diseases and the
mechanisms of their effect on the div. The formation of autoimmune diseases in the div
is associated with the following pathological processes:
- Autoimmune inflammation - Autoimmune diseases attack the div's own cells and tissues,
initiating the inflammatory process.
- Genetic predisposition - In some people, the predisposition to autoimmune diseases may be
due to genetic factors.
- Environmental factors - Viral infections, radiation, and exposure to toxic substances can
trigger an autoimmune response.
- Immune system dysfunction - The immune system can become inappropriately activated,
causing the div to attack itself.
Pathological physiology studies these processes in detail, helping to better understand
autoimmune diseases and develop ways to prevent them. Autoimmune disease diagnostics
are important in identifying autoimmune diseases, assessing their activity, and making
differential diagnoses. This analysis is used to diagnose autoimmune diseases such as
systemic lupus erythematosus (SLE), scleroderma, Sjogren's syndrome, mixed connective
tissue disease, dermatomyositis, and polymyositis. An increase in the titer of autoimmune
diseases may indicate the severity of the disease, for example, a high anti-dsDNA titer
indicates an active phase of SLE. Autoimmune disease analysis also plays an important role
in assessing the effectiveness of treatment, since a decrease in the titer indicates that the
disease is entering remission. This analysis is also used in differential diagnosis to
distinguish autoimmune diseases from other inflammatory or infectious diseases. For
example, anti-centromere antibodies help distinguish scleroderma from other connective
tissue diseases. Diagnosis of autoimmune diseases is carried out using various laboratory
methods and is assessed in conjunction with clinical symptoms.
Conclusion
Diagnosis of antibodies to nuclear antigens is one of the important laboratory methods for
detecting autoimmune diseases, assessing their activity level and making differential
diagnosis. This analysis plays an important role in the diagnosis of autoimmune diseases
such as systemic lupus erythematosus (SLE), scleroderma, Sjogren's syndrome, mixed
connective tissue disease, dermatomyositis and polymyositis. The results of the analysis of
autoimmune diseases are also used to assess the activity of the disease, the dynamics of its
course and the effectiveness of treatment. An increase or decrease in the titer of autoimmune
Vo
lu
m
e
5,
M
ar
ch
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
diseases is associated with the clinical course of the disease and provides information about
increased disease activity, remission or exacerbation processes. For example, a high titer of
anti-dsDNA antibodies is detected in the active phase of systemic lupus erythematosus,
while anti-centromere antibodies are associated with scleroderma. Therefore, determining
the type and titer of autoimmune diseases is of great importance in determining the
prognosis of the disease and developing an individual treatment plan. Autoimmune diseases
are diagnosed using various laboratory methods, including immunofluorescence microscopy,
ELISA, and Western blot. Each method has its own advantages and requires careful
interpretation of the results. If the results of these tests are not evaluated in conjunction with
clinical symptoms and other laboratory tests, there is a risk of misdiagnosis. Given the
complexity and multifaceted nature of autoimmune diseases, autoimmune disease testing
should not be used as the only diagnostic tool, but as a comprehensive assessment of the
clinical situation. Properly performed autoimmune disease testing is of great importance for
early detection of the disease, monitoring its course, and developing an effective treatment
strategy for patients. Therefore, autoimmune disease testing is an integral part of clinical
practice related to autoimmune diseases, and its correct use is of great importance for
doctors in the diagnostic process.
References
1.
Tan, E. M., & Chan, E. K. (2015). Antinuclear Antibodies and Autoimmunity.
Clinical Immunology, 157(1), 1-12.
2.
Pisetsky, D. S. (2017). Antinuclear Antidiv Testing – Methods and Clinical
Applications. The Journal of Rheumatology, 44(5), 645-653.
3.
Mahler, M., & Fritzler, M. J. (2019). The Clinical Relevance of Antinuclear
Antidiv Testing in Autoimmune Diseases. Autoimmunity Reviews, 18(2), 102-113.
4.
American College of Rheumatology. (2020). Guidelines for Antinuclear Antidiv
(ANA) Testing.
5.
Satoh, M., & Chan, E. K. (2018). Clinical Significance of Antinuclear Antibodies in
Systemic Autoimmune Diseases. Frontiers in Immunology, 9, 684.
6.
Shoenfeld, Y., Gershwin, M. E., & Meroni, P. L. (2013). Autoantibodies in Systemic
Autoimmune Diseases. Elsevier.
7.
Watanabe, A., & Komatsu, H. (2021). Current Perspectives on Autoimmune
Disorders and ANA Testing. Clinical and Experimental Rheumatology, 39(3), 451-460.
8.
Kumar, Y., & Bhatia, A. (2017). Antinuclear Antibodies: Current Concepts in
Immunodiagnostics. Indian Journal of Clinical Biochemistry, 32(1), 9-21.
